Delivery Order SPE2DB20D3103-SPE2DB21FM8L8
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to the U.S. government, primarily supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, awarded by the Defense Logistics Agency (DLA), is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and runs through November 2026. This single-award IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to support the healthcare needs of the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, awarded by the Defense Logistics Agency (DLA), is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, awarded by the Defense Logistics Agency (DLA), is a $999,999,999.00 Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver essential...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, awarded by the Defense Logistics Agency (DLA), is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and runs through December 2025. It serves as the primary vehicle for Amerisourcebergen to deliver...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of a wide range of prescription medications, over-the-counter drugs, and medical supplies to the U.S. Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to support various U.S. government healthcare programs, particularly within the Department of Defense (DOD) and Department of Veterans Affairs (VA). The contract, awarded by the Defense Logistics Agency (DLA), is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and runs through November 2026. It serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The contract, awarded by the Defense Logistics Agency (DLA), is a $999,999,999.00 Indefinite Delivery Contract (IDC) that runs through November 2026. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a wide range of pharmaceutical products and medical supplies to support U.S. government healthcare programs, particularly those of the Department of Defense (DOD) and Department of Veterans Affairs (VA). The contract, awarded by the Defense Logistics Agency (DLA), is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and runs through November 2026. It...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of a broad range of pharmaceutical products and medical supplies to support U.S. government healthcare programs, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, awarded by the Defense Logistics Agency (DLA), is a $999,999,999 Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to provide...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FM8L8Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, awarded by the Defense Logistics Agency (DLA), is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 3/17/21 |